CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 109 enrolled
Drug / intervention
Rocuroniumdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02553629
NCT02553629Phase 4Completed
CompareCT.gov

Effect of Depth of Neuromuscular Block on Intraoperative Surgical Conditions as Determined by the Leiden Surgical Rating Scale in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery

Leiden University Medical Center·interventional·Posted Sep 17, 2015·Updated Feb 3, 2017

In Brief

A Phase 4 clinical trial evaluating Rocuronium for Surgical Conditions. Completed, enrolled 109 participants across 2 sites.

Detailed Summary

This is a randomized control trial (RCT) that studies the surgical conditions during moderate and deep neuromuscular blockade in 100 morbidly obese patients receiving elective laparoscopic surgery for bariatric surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSurgical Conditions
CountriesNetherlands
CollaboratorsMerck Sharp & Dohme LLC, Medical Center Haaglanden

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 17, 2015
Enrollment StartSep 1, 2015
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.8 years ago

Interventions

Rocuroniumdrug